SCYNEXIS

Finding new fronts in the fight against fungal disease.

SCYNEXIS is a publicly traded anti-invectives company whose business is transforming at pace. Its innovations give healthcare professionals powerful new ways of treating serious and deadly fungal infections in a hospital setting.

DESIGN LEAD